OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
Linyang Gan, Huan Chen, Xiaowei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Linyang Gan, Huan Chen, Xiaowei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Showing 12 citing articles:
Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review
Huixin Zhang, Lysa Houadj, Kevin Y. Wu, et al.
Diagnostics (2024) Vol. 14, Iss. 3, pp. 336-336
Open Access | Times Cited: 9
Huixin Zhang, Lysa Houadj, Kevin Y. Wu, et al.
Diagnostics (2024) Vol. 14, Iss. 3, pp. 336-336
Open Access | Times Cited: 9
Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
A Javaid, Catherine Bennett, Aparna D. Rao, et al.
Pharmaceutical Medicine (2024) Vol. 38, Iss. 1, pp. 25-38
Open Access | Times Cited: 7
A Javaid, Catherine Bennett, Aparna D. Rao, et al.
Pharmaceutical Medicine (2024) Vol. 38, Iss. 1, pp. 25-38
Open Access | Times Cited: 7
Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy
Oren Tomkins‐Netzer, Rachael L. Niederer, John Greenwood, et al.
Progress in Retinal and Eye Research (2024) Vol. 99, pp. 101245-101245
Open Access | Times Cited: 6
Oren Tomkins‐Netzer, Rachael L. Niederer, John Greenwood, et al.
Progress in Retinal and Eye Research (2024) Vol. 99, pp. 101245-101245
Open Access | Times Cited: 6
Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors
Eileen Chang, Renee Liu, Kiandokht Keyhanian, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e011049-e011049
Open Access
Eileen Chang, Renee Liu, Kiandokht Keyhanian, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e011049-e011049
Open Access
Corneal ulcer development due to sintilimab-anlotinib combination therapy-induced dry eye: a case report
Xiaolan Xiang, Waner Lin, Xiaoying Guan, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 5, pp. 2571-2579
Open Access | Times Cited: 3
Xiaolan Xiang, Waner Lin, Xiaoying Guan, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 5, pp. 2571-2579
Open Access | Times Cited: 3
Ophthalmic Immune-Related Adverse Events and Association with Survival: Results from a Real-World Database
Lee Quiruz, Negin Yavari, Bijal Kikani, et al.
American Journal of Ophthalmology (2024)
Closed Access | Times Cited: 2
Lee Quiruz, Negin Yavari, Bijal Kikani, et al.
American Journal of Ophthalmology (2024)
Closed Access | Times Cited: 2
Emerging Ocular Side Effects of Immune Checkpoint Inhibitors: A Comprehensive Review
Kevin Y. Wu, Yoel Yakobi, Diana Danielova Gueorguieva, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2547-2547
Open Access | Times Cited: 1
Kevin Y. Wu, Yoel Yakobi, Diana Danielova Gueorguieva, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2547-2547
Open Access | Times Cited: 1
Iatrogenic affectation of ocular motility by immune checkpoint inhibitors
H. Fernández Jiménez-Ortiz, B. Maroto Rodríguez, R. Lapuente Monjas, et al.
Archivos de la Sociedad Española de Oftalmología (English Edition) (2023) Vol. 99, Iss. 4, pp. 158-164
Closed Access | Times Cited: 1
H. Fernández Jiménez-Ortiz, B. Maroto Rodríguez, R. Lapuente Monjas, et al.
Archivos de la Sociedad Española de Oftalmología (English Edition) (2023) Vol. 99, Iss. 4, pp. 158-164
Closed Access | Times Cited: 1
Immune Checkpoints and Graves’ Disease, Thyroid Eye Disease, and Orbital Myopathy: A Comprehensive Review
Zahra Souri, Farzad Pakdel
Journal of Ophthalmic and Vision Research (2024)
Open Access
Zahra Souri, Farzad Pakdel
Journal of Ophthalmic and Vision Research (2024)
Open Access
Ocular Immune-Related Adverse Events Associated with PD-1 Inhibitors: From Molecular Mechanisms to Clinical Management
Yuqi Gong, Yushuai Liu, Fagang Jiang, et al.
Seminars in Ophthalmology (2024), pp. 1-18
Closed Access
Yuqi Gong, Yushuai Liu, Fagang Jiang, et al.
Seminars in Ophthalmology (2024), pp. 1-18
Closed Access
Afectación iatrogénica de la motilidad ocular por fármacos antitumorales inhibidores de los puntos de control
H. Fernández Jiménez-Ortiz, B. Maroto Rodríguez, R. Lapuente Monjas, et al.
Archivos de la Sociedad Española de Oftalmología (2023) Vol. 99, Iss. 4, pp. 158-164
Closed Access
H. Fernández Jiménez-Ortiz, B. Maroto Rodríguez, R. Lapuente Monjas, et al.
Archivos de la Sociedad Española de Oftalmología (2023) Vol. 99, Iss. 4, pp. 158-164
Closed Access
